Y65F (p.Tyr65Phe) variant of KRT13 (Keratin, type I cytoskeletal 13)

Y65F (p.Tyr65Phe) in KRT13 (Keratin, type I cytoskeletal 13) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.08 / 1. The record also includes population frequency data and structural context.

Y65F (p.Tyr65Phe) variant details